Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 185

1.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators.

Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23.

2.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, Janavicius R, Hansen Tv, Nielsen FC, Ejlertsen B, Osorio A, Muñoz-Repeto I, Durán M, Godino J, Pertesi M, Benítez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Bonanni B, Viel A, Pasini B, Papi L, Ottini L, Savarese A, Bernard L, Radice P, Hamann U, Verheus M, Meijers-Heijboer HE, Wijnen J, Gómez García EB, Nelen MR, Kets CM, Seynaeve C, Tilanus-Linthorst MM, van der Luijt RB, van Os T, Rookus M, Frost D, Jones JL, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Cook J, Donaldson A, Dorkins H, Gregory H, Eason J, Houghton C, Barwell J, Side LE, McCann E, Murray A, Peock S, Godwin AK, Schmutzler RK, Rhiem K, Engel C, Meindl A, Ruehl I, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Kast K, Preisler-Adams S, Varon-Mateeva R, Schoenbuchner I, Fiebig B, Heinritz W, Schäfer D, Gevensleben H, Caux-Moncoutier V, Fassy-Colcombet M, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Hardouin A, Berthet P, Muller D, Fricker JP, Mortemousque I, Pujol P, Coupier I, Lebrun M, Kientz C, Longy M, Sevenet N, Stoppa-Lyonnet D, Isaacs C, Caldes T, de la Hoya M, Heikkinen T, Aittomäki K, Blanco I, Lazaro C, Barkardottir RB, Soucy P, Dumont M, Simard J, Montagna M, Tognazzo S, D'Andrea E, Fox S, Yan M, Rebbeck T, Olopade O, Weitzel JN, Lynch HT, Ganz PA, Tomlinson GE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet M, Bhatia J, Kauff N, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Mai PL, Greene MH, Imyanitov E, O'Malley FP, Ozcelik H, Glendon G, Toland AE, Gerdes AM, Thomassen M, Kruse TA, Jensen UB, Skytte AB, Caligo MA, Soller M, Henriksson K, Wachenfeldt vA, Arver B, Stenmark-Askmalm M, Karlsson P, Ding YC, Neuhausen SL, Beattie M, Pharoah PD, Moysich KB, Nathanson KL, Karlan BY, Gross J, John EM, Daly MB, Buys SM, Southey MC, Hopper JL, Terry MB, Chung W, Miron AF, Goldgar D, Chenevix-Trench G, Easton DF, Andrulis IL, Antoniou AC; Breast Cancer Family Registry; EMBRACE; GEMO Study Collaborators; HEBON; kConFab Investigators; Ontario Cancer Genetics Network; SWE-BRCA; CIMBA.

Breast Cancer Res. 2011;13(6):R110. doi: 10.1186/bcr3052. Epub 2011 Nov 2.

3.

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, Barnes D; Gemo Study Collaborators, Antoniou AC, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S.

Hum Mutat. 2011 Sep;32(9):1004-7. doi: 10.1002/humu.21539. Epub 2011 Jul 12.

PMID:
21591024
4.

[Influence exerted by 2 steroid alkaloids, funtumine and irehdiamine A, on hepato-carcinogenesis induced in the rat with p-dimethylamino-azobenzene (DAB)].

Lacassagne A, Hurst L, Dat-Xuong N, Khuong-Huu Q, Goutarel R.

C R Acad Sci Hebd Seances Acad Sci D. 1972 May 15;274(20):2830-2. French. No abstract available.

PMID:
4625391
5.

[Effect of hormonal steroids on hepatocancerogenesis induced by paradimethylaminoazobenzene].

Lacassagne A, Jayle MF, Hurst L.

Bull Acad Natl Med. 1972 Feb 15;156(6):214-20. French. No abstract available.

PMID:
4630019
6.

[Influence exerted by various estrogens on the process of liver cancerization in male rats poisoned by para-dimethylaminoazobenzene (DAB)].

Lacassagne A, Jayle MF, Hurst L, de Lauzon S.

C R Acad Sci Hebd Seances Acad Sci D. 1972 Feb 7;274(6):970-2. French. No abstract available.

PMID:
4622887
7.

[Influence of pregnandiol and allopregnandiol on the process of liver cancerization in male rats poisoned by para dimethylaminoazobenzene (DAB)].

Lacassagne A, Jayle MF, Hurst L, Desfosses B.

C R Acad Sci Hebd Seances Acad Sci D. 1972 Jan 3;274(1):141-3. French. No abstract available.

PMID:
4622030
8.

Historical outline of the initial studies on the use of polonium in biology.

Lacassagne A.

Br J Radiol. 1971 Jul;44(523):546-8. No abstract available.

PMID:
4933120
9.

[Carcinogenic properties of 5-oxo-5 H-benzo(e)isochromeno(4,3-b)indole and its derivatives and analogues: relations between structure and activity].

Lacassagne A, Buu-Hoï NP, Zajdela F, Stora C, Mangane M, Jacquignon P.

C R Acad Sci Hebd Seances Acad Sci D. 1971 Jun 14;272(24):3102-4. French. No abstract available.

PMID:
4997332
10.

[Critical review of experimental Leydig cell tumors, particularly in rats].

Lacassagne A.

Bull Cancer. 1971 Apr-Jun;58(2):235-75. Review. French. No abstract available.

PMID:
5004047
11.
12.

[Inhibition by 2 naphtylisothiocyanates of hepatocarcinogenesis induced by p-dimethylaminoazobenzene (DAB) in rats].

Lacassagne A, Hurst L, Xuong MD.

C R Seances Soc Biol Fil. 1970 Sep 25;164(2):230-3. French. No abstract available.

PMID:
4249107
13.

[Effects, on the liver and testis, of ethionine associated with butter yellow].

Lacassagne A, Hurst L.

Bull Cancer. 1970 Jul-Sep;57(3):365-79. French. No abstract available.

PMID:
4993732
14.

[Contrary to reserpine, yohimbine does not alter rat liver chemical carcinogenesis].

Lacassagne A.

C R Acad Sci Hebd Seances Acad Sci D. 1970 Feb 2;207(5):746-7. French. No abstract available.

PMID:
4985043
15.

[Effect of hypo- and hyperglycemic sulfonamides on the cancerous process of rat liver by 2-acetylaminofluorene].

Lacassagne A, Hurst L.

Bull Cancer. 1969 Oct-Dec;56(4):397-410. French. No abstract available.

PMID:
4928249
16.

[Effect of epiphysectomy on chemical hepatocancerogenesis in rats].

Lacassagne A, Chamorro A, Hurst L, Nguyen-Ba-Giao.

C R Acad Sci Hebd Seances Acad Sci D. 1969 Sep 15;269(11):1043-6. French. No abstract available.

PMID:
4981428
17.

[Reciprocal effect of 7,12-dimethylbenz(a)anthracene (DMBA) and of para-dimethylaminoazobenzene (DAB) administered simultaneously to rats].

Lacassagne A, Hurst L.

Bull Cancer. 1969 Apr-Jun;56(2):169-76. French. No abstract available.

PMID:
4994834
18.

[Action of C 21 steroids on cancerization of rat liver by para-dimethylaminoazobenzene (DAB)].

Lacassagne A, Jayle MF, Hurst L.

C R Acad Sci Hebd Seances Acad Sci D. 1969 Jan 27;268(4):740-3. French. No abstract available.

PMID:
4989972
19.

[New study of the influence exercised, by the nature and the number of the substituants, on cancerogenous activity of the angular benzacridines].

Lacassagne A, Buu-Hoï NP, Zajdela F, Giao NB, Jacquignon P, Dufour M.

C R Acad Sci Hebd Seances Acad Sci D. 1968 Sep 2;267(10):981-3. French. No abstract available.

PMID:
4973092
20.

[Influence exercised by different estrogens on the cancerization of rat liver by para-dimethyl-amino-azobenzene (DAB)].

Lacassagne A, Jayle MF, Hurst L.

C R Acad Sci Hebd Seances Acad Sci D. 1968 Jul 1;267(1):137-40. French. No abstract available.

PMID:
4971523

Supplemental Content

Loading ...
Support Center